FUJIFILM Acquires Cell Therapy Manufacturing Facility from Atara
A 90,000 ft2 manufacturing facility in Thousand Oaks, CA, is readily expandable with the flexibility to produce both clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies, according to officials at FUJIFILM Diosynth Biotechnologies, a CDMO. The manufacturing facility complements FUJIFILM’s existing manufacturing operations in College Station, TX, Watertown, MA, and its BioCampus in the UK.
Source: genengnews.com